ATF2 and glioma: Recent studies show that miR-622 is associated with tumor metastatic capability in gastric cancers [57] and can suppress glioma invasion and migration by directly targeting activating transcription factor ATF2 [58], but no data have been released about a miR-622 neuromodulation activity.